|
DE10399023I2
(de)
|
1989-09-12 |
2006-11-23 |
Ahp Mfg B V |
TFN-bindende Proteine
|
|
US5705364A
(en)
†
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
|
US6656466B1
(en)
*
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
|
JP4306813B2
(ja)
|
1995-09-19 |
2009-08-05 |
アスビオファーマ株式会社 |
動物細胞の新規培養方法
|
|
KR20000010825A
(ko)
*
|
1996-05-08 |
2000-02-25 |
프리돌린 클라우스너, 롤란드 비. 보레르 |
종양괴사인자 수용체-면역 글로불린 융합 단백질을 사용한 천식의 치료방법
|
|
AU2051899A
(en)
*
|
1997-12-03 |
1999-06-16 |
Roche Diagnostics Gmbh |
Method for preparing polypeptides with appropriate glycosilation
|
|
US6140445A
(en)
*
|
1998-04-17 |
2000-10-31 |
Crompton Corporation |
Silane functional oligomer
|
|
AU4314299A
(en)
*
|
1998-05-29 |
1999-12-13 |
Genentech Inc. |
Cell culture process for producing glycoproteins
|
|
US6528286B1
(en)
*
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
|
TR200504220T2
(tr)
|
1998-12-17 |
2007-04-24 |
Biogen Idec Ma Inc. |
Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
|
|
GB9828624D0
(en)
*
|
1998-12-23 |
1999-02-17 |
Glaxo Group Ltd |
Production of proteins
|
|
KR100475417B1
(ko)
*
|
1998-12-30 |
2005-07-18 |
씨제이 주식회사 |
시알산 함량이 높은 재조합 당단백질의 제조방법
|
|
US7294481B1
(en)
*
|
1999-01-05 |
2007-11-13 |
Immunex Corporation |
Method for producing recombinant proteins
|
|
DE60032349T2
(de)
|
1999-04-26 |
2007-07-12 |
Genentech, Inc., South San Francisco |
Zellenzuchtverfahren für glycoproteine
|
|
US6261805B1
(en)
*
|
1999-07-15 |
2001-07-17 |
Boyce Thompson Institute For Plant Research, Inc. |
Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
|
|
KR100394474B1
(ko)
*
|
1999-12-18 |
2003-08-09 |
동아제약 주식회사 |
동물세포에서 재조합 당단백질의 연속식 대량생산 방법
|
|
ES2256234T3
(es)
*
|
2000-05-16 |
2006-07-16 |
Lipoxen Technologies Limited |
Derivatizacion de proteinas en solucion acuosa.
|
|
AU2001271021A1
(en)
*
|
2000-07-05 |
2002-01-14 |
Japan As Represented By Secretary Of Osaka University |
Process for producing glycoprotein
|
|
US20030040095A1
(en)
*
|
2001-03-16 |
2003-02-27 |
Achille Arini |
Method for the production of pharmaceutically active recombinant proteins
|
|
EP1404813A4
(en)
*
|
2001-06-13 |
2004-11-24 |
Genentech Inc |
METHOD FOR CULTIVATING ANIMAL CELLS AND POLYPEPTIDE PRODUCTION IN ANIMAL CELLS
|
|
EP1497444B1
(en)
|
2002-03-27 |
2015-11-04 |
Immunex Corporation |
Methods for increasing polypeptide production
|
|
US20030190710A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Devries Ruth L. |
Control of glycoforms in IgG
|
|
US6974681B1
(en)
|
2002-08-23 |
2005-12-13 |
Immunex Corporation |
Cell culture performance with vanadate
|
|
US6924124B1
(en)
*
|
2002-08-23 |
2005-08-02 |
Immunex Corporation |
Feeding strategies for cell culture
|
|
US7067279B1
(en)
|
2002-08-23 |
2006-06-27 |
Immunex Corporation |
Cell culture performance with betaine
|
|
EP1578799B8
(en)
*
|
2002-12-02 |
2011-03-23 |
Amgen Fremont Inc. |
Antibodies directed to tumor necrosis factor and uses thereof
|
|
CN100402660C
(zh)
*
|
2002-12-23 |
2008-07-16 |
布里斯托尔-迈尔斯斯奎布公司 |
用于蛋白质生产的哺乳动物细胞培养方法中产物质量提高
|
|
CN101857851A
(zh)
*
|
2002-12-23 |
2010-10-13 |
布里斯托尔-迈尔斯斯奎布公司 |
用于蛋白质生产的哺乳动物细胞培养方法
|
|
MXPA05011486A
(es)
*
|
2003-04-25 |
2006-04-18 |
Immunex Corp |
Inductores de expresion de proteina recombinante.
|
|
SG147468A1
(en)
|
2003-10-24 |
2008-11-28 |
Selexis Sa |
High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
|
|
US20070099266A1
(en)
*
|
2003-12-23 |
2007-05-03 |
Applied Research Systems Ars Holding N.V. |
Process for the production of tumor necrosis factor-binding proteins
|
|
EP1709185A1
(en)
*
|
2003-12-31 |
2006-10-11 |
Samyang Genex Corporation |
Method for mass production of secondary metabolites in plant cell culture by treatment of an alkanoic acid or salt thereof
|
|
CN1926242B
(zh)
*
|
2004-02-13 |
2013-01-16 |
格莱克托普有限公司 |
高活性糖蛋白加工条件及其有效生产方法
|
|
US7294484B2
(en)
*
|
2004-08-27 |
2007-11-13 |
Wyeth Research Ireland Limited |
Production of polypeptides
|
|
TWI364458B
(en)
*
|
2004-08-27 |
2012-05-21 |
Wyeth Res Ireland Ltd |
Production of tnfr-lg
|
|
US7335491B2
(en)
*
|
2004-08-27 |
2008-02-26 |
Wyeth Research Ireland Limited |
Production of anti-abeta
|
|
CA2607663C
(en)
*
|
2005-05-19 |
2014-08-12 |
Amgen Inc. |
Compositions and methods for increasing the stability of antibodies
|
|
JP2008541746A
(ja)
*
|
2005-06-03 |
2008-11-27 |
ビオヴィトルム・アクチボラゲット（プブリクト） |
新規プロセス
|
|
KR100670105B1
(ko)
|
2005-06-29 |
2007-01-17 |
주식회사 셀트리온 |
콩가수분해물의 저분자량 분획을 이용하여 시알산 함량이증가된 에리스로포이에틴을 생산하는 방법 및 그에 의하여생산된 시알산 함량이 증가된 에리스로포이에틴
|
|
WO2008057634A2
(en)
*
|
2006-10-26 |
2008-05-15 |
The Rockefeller University |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
|
US8470318B2
(en)
|
2005-11-07 |
2013-06-25 |
The Rockefeller University |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
|
AR058568A1
(es)
|
2005-12-20 |
2008-02-13 |
Bristol Myers Squibb Co |
Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
|
|
SI1969007T1
(sl)
*
|
2005-12-20 |
2014-03-31 |
Bristol-Myers Squibb Company |
Sestavki in postopki za izdelavo sestavka
|
|
US20070190057A1
(en)
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
|
DK2264060T3
(da)
*
|
2006-01-26 |
2014-07-28 |
Recopharma Ab |
Sammensætninger og fremgangsmåder til inhibering af viral adhæsion
|
|
JP6084761B2
(ja)
*
|
2006-04-05 |
2017-02-22 |
ザ ロックフェラー ユニバーシティー |
抗炎症特性が増強され、細胞毒性特性が減少したポリペプチドおよび関連する方法
|
|
AU2007272957B2
(en)
*
|
2006-07-13 |
2014-05-01 |
Wyeth Llc |
Production of glycoproteins
|
|
KR20090074040A
(ko)
|
2006-09-13 |
2009-07-03 |
아보트 러보러터리즈 |
세포 배양의 개선
|
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
US20080145893A1
(en)
*
|
2006-09-17 |
2008-06-19 |
Excellegene Sa |
Method for producing a recombinant protein at high specific productivity, high batch yield and high volumetric yield by means of transient transfection
|
|
WO2008069244A1
(ja)
*
|
2006-12-05 |
2008-06-12 |
Kyowa Hakko Kogyo Co., Ltd. |
糖蛋白質組成物の製造方法
|
|
CA2682744C
(en)
*
|
2007-04-16 |
2015-10-06 |
Momenta Pharmaceuticals, Inc. |
Methods related to cell surface glyosylation
|
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
US20090023186A1
(en)
*
|
2007-07-22 |
2009-01-22 |
Excellgene Sa |
Use of valproic acid for enhancing production of recombinant proteins in mammalian cells
|
|
ES2657055T3
(es)
*
|
2007-08-09 |
2018-03-01 |
Wyeth Llc |
Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
|
|
EP4269578B8
(en)
|
2008-03-06 |
2024-07-17 |
Halozyme, Inc. |
Soluble hyaluronidase composition
|
|
TWI395593B
(zh)
*
|
2008-03-06 |
2013-05-11 |
Halozyme Inc |
可活化的基質降解酵素之活體內暫時性控制
|
|
CA2720610C
(en)
|
2008-04-07 |
2016-08-23 |
Bayer Healthcare Llc |
Methods of recombinant production of glycoproteins
|
|
MX2010011598A
(es)
|
2008-04-22 |
2010-12-15 |
Univ Rockefeller |
Metodos para identificar compuestos anti-inflamatorios.
|
|
JP5524214B2
(ja)
|
2008-09-15 |
2014-06-18 |
ジェネンテック， インコーポレイテッド |
細胞容積モル浸透圧濃度を調節するための組成物および方法
|
|
EP2350127B1
(en)
*
|
2008-10-20 |
2015-01-28 |
AbbVie Inc. |
Isolation and purification of antibodies using protein a affinity chromatography
|
|
AU2009307737B2
(en)
|
2008-10-20 |
2015-07-23 |
Abbvie Inc. |
Viral inactivation during purification of antibodies
|
|
EP2367936B1
(en)
|
2008-12-09 |
2016-03-02 |
Halozyme, Inc. |
Extended soluble ph20 polypeptides and uses thereof
|
|
US20110229451A2
(en)
*
|
2009-03-06 |
2011-09-22 |
Halozyme, Inc. |
Temperature sensitive mutants of matrix metalloproteases and uses thereof
|
|
US9540426B2
(en)
|
2009-10-06 |
2017-01-10 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
SG10201510640QA
(en)
|
2009-10-26 |
2016-01-28 |
Hoffmann La Roche |
Method For The Production Of A Glycosylated Immunoglobulin
|
|
LT2501822T
(lt)
|
2009-11-17 |
2017-10-25 |
E. R. Squibb & Sons, L.L.C. |
Padidintos baltymų produkcijos būdai
|
|
BR112012013330A2
(pt)
*
|
2009-12-02 |
2017-03-28 |
Acceleron Pharma Inc |
composições e métodos para aumentar meia vida do soro de proteínas de fusão fc
|
|
NO2538968T3
(cg-RX-API-DMAC7.html)
*
|
2010-02-24 |
2018-03-31 |
|
|
|
US20130130317A1
(en)
|
2010-08-02 |
2013-05-23 |
Kyowa Hakko Kirin Co., Ltd |
Method for producing substance
|
|
WO2012122625A1
(en)
|
2011-03-14 |
2012-09-20 |
National Research Council Of Canada |
Method of viral production in cells
|
|
US9062106B2
(en)
|
2011-04-27 |
2015-06-23 |
Abbvie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
RU2580020C2
(ru)
|
2011-04-29 |
2016-04-10 |
Биокон Рисерч Лимитед |
Способ снижения гетерогенности антител и способ получения соответствующих антител
|
|
WO2012170938A1
(en)
|
2011-06-08 |
2012-12-13 |
Acceleron Pharma Inc. |
Compositions and methods for increasing serum half-life
|
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
US9334319B2
(en)
|
2012-04-20 |
2016-05-10 |
Abbvie Inc. |
Low acidic species compositions
|
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
|
CN102839157A
(zh)
*
|
2012-07-12 |
2012-12-26 |
扬州大学 |
稳定共表达hST3GalIV和β1-4GalT1的MDCK细胞系及构建方法和应用
|
|
WO2014035475A1
(en)
|
2012-09-02 |
2014-03-06 |
Abbvie Inc. |
Methods to control protein heterogeneity
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
NO2760138T3
(cg-RX-API-DMAC7.html)
|
2012-10-01 |
2018-08-04 |
|
|
|
US20140106405A1
(en)
*
|
2012-10-15 |
2014-04-17 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
ES2633960T3
(es)
|
2012-10-15 |
2017-09-26 |
Bristol-Myers Squibb Company |
Procesos de cultivo de células de mamífero para la producción de proteínas
|
|
CA2905010A1
(en)
|
2013-03-12 |
2014-09-18 |
Abbvie Inc. |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
|
US9499614B2
(en)
|
2013-03-14 |
2016-11-22 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
|
|
US9217168B2
(en)
|
2013-03-14 |
2015-12-22 |
Momenta Pharmaceuticals, Inc. |
Methods of cell culture
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
US8921526B2
(en)
|
2013-03-14 |
2014-12-30 |
Abbvie, Inc. |
Mutated anti-TNFα antibodies and methods of their use
|
|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
|
EP3017303B1
(en)
|
2013-07-04 |
2018-01-03 |
F.Hoffmann-La Roche Ag |
Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
|
|
CN105431454A
(zh)
|
2013-07-06 |
2016-03-23 |
卡迪拉保健有限公司 |
用于生产单克隆抗体的改进方法
|
|
EP3052640A2
(en)
|
2013-10-04 |
2016-08-10 |
AbbVie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
WO2015073884A2
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
KR102280638B1
(ko)
*
|
2014-02-27 |
2021-07-22 |
에프. 호프만-라 로슈 아게 |
재조합 당단백질 제조에서의 세포 성장 및 글리코실화의 조절
|
|
JP6652334B2
(ja)
|
2014-05-31 |
2020-02-19 |
Ｊｃｒファーマ株式会社 |
ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
|
|
JP2017516484A
(ja)
*
|
2014-06-03 |
2017-06-22 |
ルピン・リミテッド |
タンパク質生産のための細胞培養工程
|
|
US20160130324A1
(en)
|
2014-10-31 |
2016-05-12 |
Shire Human Genetic Therapies, Inc. |
C1 Inhibitor Fusion Proteins and Uses Thereof
|
|
KR102007930B1
(ko)
|
2014-12-31 |
2019-08-06 |
주식회사 엘지화학 |
재조합 당단백질의 글리코실화 조절 방법
|
|
TWI870789B
(zh)
|
2015-08-04 |
2025-01-21 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
|
EP3377093B1
(en)
|
2015-11-19 |
2022-07-13 |
Takeda Pharmaceutical Company Limited |
Recombinant human c1 esterase inhibitor and uses thereof
|
|
RU2724536C2
(ru)
*
|
2015-12-29 |
2020-06-23 |
Н.В. Нютрисиа |
Ферментированная молочная смесь с неперевариваемыми олигосахаридами
|
|
EP3717656B1
(en)
*
|
2017-11-30 |
2024-03-13 |
F. Hoffmann-La Roche AG |
Process for culturing mammalian cells
|
|
CA3117447C
(en)
|
2018-11-13 |
2024-06-04 |
Janssen Biotech, Inc. |
Control of trace metals during production of anti-cd38 antibodies
|
|
US12297451B1
(en)
|
2019-10-25 |
2025-05-13 |
Regeneron Pharmaceuticals, Inc. |
Cell culture medium
|
|
CA3159586A1
(en)
|
2019-12-06 |
2021-06-10 |
Regeneron Pharmaceuticals, Inc. |
Anti-vegf protein compositions and methods for producing the same
|
|
JP2023525034A
(ja)
|
2020-05-08 |
2023-06-14 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ｖｅｇｆトラップおよびミニトラップならびに眼障害およびがんの治療方法
|
|
MX2023002417A
(es)
|
2020-08-31 |
2023-03-22 |
Regeneron Pharma |
Estrategias de suministro de asparagina para mejorar el rendimiento del cultivo celular y mitigar las variantes de secuencia de asparagina.
|
|
JP2024503408A
(ja)
|
2021-01-20 |
2024-01-25 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
細胞培養におけるタンパク質力価の改善方法
|
|
WO2023059800A2
(en)
|
2021-10-07 |
2023-04-13 |
Regeneron Pharmaceuticals, Inc. |
Systems and methods of ph modeling and control
|
|
CN118076885A
(zh)
|
2021-10-07 |
2024-05-24 |
里珍纳龙药品有限公司 |
pH计校准与校正
|
|
KR20240167714A
(ko)
|
2022-03-02 |
2024-11-27 |
리제너론 파아마슈티컬스, 인크. |
고역가 항체의 제조 방법
|
|
WO2025219232A1
(en)
|
2024-04-15 |
2025-10-23 |
Evonik Operations Gmbh |
Application of small peptides supplemented cell culture media for improved cell performance
|